News

June 15, 2012 — At the Society of Nuclear Medicine’s (SNM) 59th Annual Meeting in Miami Beach, Fla., June 9-12, Cardinal Health introduced new technology enhancements that make it possible...

June 13, 2012 — Positron Corp. announced completion of its first strontium validation effort in May 2012, when Manhattan Isotope Technology (MIT), a Positron subsidiary, successfully...

Best Cyclotron Systems is unveiling five new cyclotrons for isotope research and production at the Society of Nuclear Medicine (SNM) 2012 Annual Meeting on June 9-12 in Miami Beach, Fla.

May 14, 2012 — Lantheus Medical Imaging Inc. announced new manufacturing and supply agreements with Jubilant HollisterStier LLC (JHS). Under separate agreements, JHS will manufacture Cardiolite...

April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the company's radiopharmaceutical...

April 5, 2012 - SK Capital Partners, a U.S. based private investment firm, and IBA (Ion Beam Applications S.A.) announced that they have closed on their previously announced agreement to create...

March 9, 2012 — Researchers have developed a method to label transplanted cells so they can be tracked by magnetic resonance imaging (MRI). In the future, as cell therapies become a more integral...

March 1, 2012 — Cell>Point announced it entered into a licensing agreement for South Korea, Taiwan, Malaysia, Vietnam and the Philippines with Hyun Imc Co. Ltd., headquartered in Seoul, South...

February 24, 2012 — Positron Corp., through its wholly owned subsidiary, Manhattan Isotope Technology LLC (MIT), announced it had received its first shipment of strontium-82 (Sr-82) from the...

January 30, 2012 — Positron Corp., a molecular imaging healthcare company specializing in the field of nuclear cardiology, announced Jan. 23 that its wholly owned subsidiary, Manhattan Isotope...

January 20, 2012 – Nuclear cardiology imaging company Positron Corp. this week acquired Manhattan Isotope Technology LLC (MIT). Positron has acquired all of the assets, business operations and...

January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary...

January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac perfusion radiotracer with a list of actions to bring the product back to market.

October 31, 2011 –Lantheus Medical announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare alliance, for...

August 24, 2011 -- Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems, such as cardiac, cancer or neurology, and/or treat certain conditions such as cancers....

The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using CardioGen-82 for cardiac positron emission tomography (PET) scans. The manufacturer, Bracco...

June 10, 2011 — At the Society of Nuclear Medicine’s 58th Annual Meeting in San Antonio, June 4-8, Cardinal Health previewed The Center for the Advancement of Molecular Imaging (The Center), its new...
June 8, 2011 – Research introduced at the Society of Nuclear Medicine's 58th annual meeting this week may lead to much-needed cardiovascular disease screening for diabetic patients at risk of...
Expanding upon its radiopharmacy platform, GE Healthcare is introducing new tracers to the FASTlab multi-tracer platform, an advanced positron emission tomography (PET) chemistry system on which the...
May 20, 2011 -- Medrad Inc., a business of Bayer HealthCare, has announced the launch of the next generation Intego PET Infusion System, which features a new design that is 38 percent smaller, power-...